Ciproxin HC, Ohrentropfen, Suspension

7680548070159 CH-54807 Ohrentropfen
Ciproxin HC, Ohrentropfen, Suspension
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
10
Selling units
10
Measure
ml
Galenic form
Ohrentropfen
Galenic group
Tropfen

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/04/2024
Patient information leaflet
Français
12/04/2024
Patient information leaflet
Italien
12/04/2024
Summary of Product Characteristics
Allemand
11/04/2024
Summary of Product Characteristics
Français
11/04/2024
Summary of Product Characteristics
Italien
11/04/2024

Detailed composition

Substance Quantity Type Category
ciprofloxacinum
2.0 MG Substance Wirkstoff (Principe actif)
ciprofloxacini hydrochloridum
2.329 MG Substance WIZUS
hydrocortisonum
10.0 MG Substance Wirkstoff (Principe actif)
polysorbatum 20
- Substance HNIDK
natrii acetas trihydricus
- Substance HNIDK
acidum aceticum glaciale
- Substance HNIDK
lecithinum ex soja hydrogenatum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK
aqua
- Substance HNIDK
alcohol benzylicus
9.0 MG Substance HBESI

Reimbursement information

Public price
CHF 15.65
Specialties list
Yes
Generic
No
SL addition date: 15/04/2000

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
54807
Drug name
Ciproxin HC, Ohrentropfen, Suspension
Galenic form
OHRT
ATC Code
S02CA03
Authorization status
Z
Dispensing category
B
First authorization
22/12/1998
Authorization expiration date
31/12/9999
IT Number
12.01.3.
Domain
Human medicine
Field of application
Otitis externa

Package details

Description (FR)
CIPROXIN HC susp auric fl 10 ml
Description (DE)
CIPROXIN HC Susp Auric Fl 10 ml
Market launch
22/12/1998
Narcotic (BTM)
No
Buy us a coffee Explore the data